FDA Device Intelligence
Home › Heraeus Medical GmbH › OSTEOPAL®

OSTEOPAL®

Heraeus Medical GmbH · Model V · UDI-DI 04260102139411

LODNDN Prescription
1
510(k) clearances
13,200
Adverse events (469 deaths)
36
Recalls
82
Facilities

Description

OSTEOPAL® V is a standard-setting, low-viscosity, radiopaque, poly(methyl methacrylate)-based (PMMA) bone cement. It contains the X-ray contrast medium zirconium dioxide. To improve visibility in the surgical field, it has been colored with chlorophyll-copper-complex (E141). The bone cement consists of two components and is prepared immediately before use by mixing the polymer powder with the monomer liquid. The low viscosity increases with progressing polymerization. A paste forms that is inserted into the vertebral body using an application system and sets within a few minutes. OSTEOPAL® V is intended for single use and is supplied sterile.

Recalls

DateFirmReason
2026-08-20Heraeus Medical GmbH (Dental Division)Potential for monomer liquid leakage.
2026-08-20Heraeus Medical GmbH (Dental Division)Potential for monomer liquid leakage.
2025-12-09Heraeus Medical GmbH (Dental Division)increase of complaints regarding the breakage of the ampoules within their device systems. An extensive investigation revealed that multiple factors have an impact on the ampoule b
2025-12-09Heraeus Medical GmbH (Dental Division)increase of complaints regarding the breakage of the ampoules within their device systems. An extensive investigation revealed that multiple factors have an impact on the ampoule b
2025-12-09Heraeus Medical GmbH (Dental Division)increase of complaints regarding the breakage of the ampoules within their device systems. An extensive investigation revealed that multiple factors have an impact on the ampoule b
2025-12-09Heraeus Medical GmbH (Dental Division)increase of complaints regarding the breakage of the ampoules within their device systems. An extensive investigation revealed that multiple factors have an impact on the ampoule b
2022-11-07Howmedica Osteonics Corp.Instructions for Use (IFU) included in the packaging is missing a translation in the Turkish language. Although the Turkish translation is missing, all content within the IFUs is
2022-11-07Howmedica Osteonics Corp.Instructions for Use (IFU) included in the packaging is missing a translation in the Turkish language. Although the Turkish translation is missing, all content within the IFUs is
2021-03-22BIOPSYBELL S.R.L.Products labeled as sterile were distributed, but may not have been sterilized.
2021-03-22BIOPSYBELL S.R.L.Products labeled as sterile were distributed, but may not have been sterilized.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.